Are pulmonologists well aware of planning safe air travel for patients with COPD? The SAFCOP study.


Journal

International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481

Informations de publication

Date de publication:
2019
Historique:
received: 02 04 2019
accepted: 01 08 2019
entrez: 6 11 2019
pubmed: 7 11 2019
medline: 14 4 2020
Statut: epublish

Résumé

Patients with respiratory diseases are more prone to health risks of air travel. The aim of this study was to investigate the current knowledge and attitudes of Turkish pulmonary physicians for air travel in patients with chronic obstructive pulmonary disease (COPD). A questionnaire was developed and administered either by congress mobile phone application or by e-mail. A total of 242 physicians participated in the study (75 by mobile phone application and 167 through the e-mail). Among participants, only 30.6% reported that they usually inform COPD patients about possible risks of air travel in their routine practice. A preflight assessment was performed by 61.2% of them and a fit to fly report was prepared by 34.3%. The most common methods/tests used for preflight assessment were reported as oxygen saturation with pulse oximetry, arterial blood gas analysis, and pulmonary function tests (51.2%, 50.8%, and 49.6%, respectively). When the participants were asked to plan safe air travel in two clinical case scenarios, only 16.2% were able to answer both cases correctly. This study shows that a standard approach for preflight assessment in patients with COPD is lacking and an active initiative is needed to increase awareness and education for fit to fly concept for COPD among pulmonologists.

Sections du résumé

Background
Patients with respiratory diseases are more prone to health risks of air travel.
Purpose
The aim of this study was to investigate the current knowledge and attitudes of Turkish pulmonary physicians for air travel in patients with chronic obstructive pulmonary disease (COPD).
Participants and methods
A questionnaire was developed and administered either by congress mobile phone application or by e-mail. A total of 242 physicians participated in the study (75 by mobile phone application and 167 through the e-mail).
Results
Among participants, only 30.6% reported that they usually inform COPD patients about possible risks of air travel in their routine practice. A preflight assessment was performed by 61.2% of them and a fit to fly report was prepared by 34.3%. The most common methods/tests used for preflight assessment were reported as oxygen saturation with pulse oximetry, arterial blood gas analysis, and pulmonary function tests (51.2%, 50.8%, and 49.6%, respectively). When the participants were asked to plan safe air travel in two clinical case scenarios, only 16.2% were able to answer both cases correctly.
Conclusion
This study shows that a standard approach for preflight assessment in patients with COPD is lacking and an active initiative is needed to increase awareness and education for fit to fly concept for COPD among pulmonologists.

Identifiants

pubmed: 31686801
doi: 10.2147/COPD.S210854
pii: 210854
pmc: PMC6709818
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1895-1900

Informations de copyright

© 2019 Ergan et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interests in this work.

Références

Thorax. 2012 Nov;67(11):964-9
pubmed: 22767877
Emerg Med J. 2005 Sep;22(9):658-9
pubmed: 16113194
Respir Med. 2011 Jan;105(1):50-6
pubmed: 20974527
Respiration. 2010;80(2):161-70
pubmed: 20395674
Aviat Space Environ Med. 2008 May;79(5):518-24
pubmed: 18500050
Eur Respir J. 2000 Jan;15(1):128-30
pubmed: 10678633
Eur Respir J. 2007 Dec;30(6):1057-63
pubmed: 17690127
Eur Respir J. 2013 Nov;42(5):1216-23
pubmed: 23258777
Eur Respir J. 2000 Apr;15(4):635-9
pubmed: 10780752
Eur Respir J. 2005 Apr;25(4):725-30
pubmed: 15802350
Chest. 2008 Apr;133(4):920-6
pubmed: 17989155
Thorax. 2011 Sep;66 Suppl 1:i1-30
pubmed: 21856702
N Engl J Med. 2013 May 30;368(22):2075-83
pubmed: 23718164
Eur Respir Rev. 2018 Jun 13;27(148):null
pubmed: 29898904

Auteurs

Begüm Ergan (B)

Dokuz Eylul University, School of Medicine, Department of Pulmonary and Critical Care, Izmir, Turkey.

Hüseyin Arıkan (H)

Department of Internal Medicine, Yuzuncu Yil University, Dursun Odabas Health Center, Van, Turkey.

Metin Akgün (M)

Ataturk University, School of Medicine, Department of Pulmonary Diseases, Erzurum, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH